Safety of Dose Escalation by Simultaneous Integrated Boosting Radiation Dose in Unresectable Stage III Non-Small Cell Lung Cancer

被引：0
|
作者：
Zhang, Q. [1 ]
Fu, X. [1 ]
机构：
[1] Shanghai Jiao Tong Univ, Shanghai Chest Hosp, Shanghai, Peoples R China
来源：
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS | 2016年 / 96卷 / 02期
关键词：
D O I：
10.1016/j.ijrobp.2016.06.373
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
348
引用
收藏
页码：S154 / S155
页数：2
相关论文
共 50 条
  • [1] Dose-escalation by hypofractionated simultaneous integrated boost IMRT in unresectable stage III non-small-cell lung cancer
    Zhang, Qin
    Cai, Xu-Wei
    Feng, Wen
    Yu, Wen
    Fu, Xiao-Long
    BMC CANCER, 2022, 22 (01)
  • [2] Dose-escalation by hypofractionated simultaneous integrated boost IMRT in unresectable stage III non-small-cell lung cancer
    Qin Zhang
    Xu-Wei Cai
    Wen Feng
    Wen Yu
    Xiao-Long Fu
    BMC Cancer, 22
  • [3] Radiation dose escalation in stage III non-small-cell lung cancer
    Terakedis, Breanne
    Sause, William
    FRONTIERS IN ONCOLOGY, 2011, 1
  • [4] Impact of radiation dose to the immune cells in unresectable or stage III non-small cell lung cancer in the durvalumab era
    McCall, Neal S.
    McGinnis, Hamilton S.
    Janopaul-Naylor, James R.
    Kesarwala, Aparna H.
    Tian, Sibo
    Stokes, William A.
    Shelton, Joseph W.
    Steuer, Conor E.
    Carlisle, Jennifer W.
    Leal, Ticiana
    Ramalingam, Suresh S.
    Bradley, Jeffrey D.
    Higgins, Kristin A.
    RADIOTHERAPY AND ONCOLOGY, 2022, 174 : 133 - 140
  • [5] Impact of Radiation Dose to the Immune Cells in Unresectable or Stage III Non-Small Cell Lung Cancer in the Durvalumab Era
    Mccall, N. S.
    McGinnis, H. S.
    Janopaul-Naylor, J. R.
    Kesarwala, A. H.
    Tian, S.
    Stokes, W. A.
    Shelton, J. W.
    Steuer, C. E.
    Carlisle, J. W.
    Leal, T.
    Ramalingam, S. S.
    Bradley, J. D.
    Higgins, K. A.
    JOURNAL OF THORACIC ONCOLOGY, 2022, 17 (09) : S109 - S109
  • [6] Is Intermediate Radiation Dose Escalation With Concurrent Chemotherapy for Stage III Non-Small Cell Lung Cancer Beneficial? Reply
    Rodrigues, George
    Senan, Suresh
    Palma, David
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2015, 92 (03): : 700 - 701
  • [7] Radiation dose escalation in non-small cell carcinoma of the lung
    Arriagada, R
    Komaki, R
    Cox, JD
    SEMINARS IN RADIATION ONCOLOGY, 2004, 14 (04) : 287 - 291
  • [8] Dose escalation for unresectable locally advanced non-small cell lung cancer: end of the line?
    Hong, Julian C.
    Salama, Joseph K.
    TRANSLATIONAL LUNG CANCER RESEARCH, 2016, 5 (01) : 126 - 133
  • [9] Radiation Dose Escalation in Accelerated Hyperfractionated Radiotherapy for Stage III Non-small-cell Lung Cancer
    Wada, Kentaro
    Kishi, Noriko
    Kanayama, Naoyuki
    Hirata, Takero
    Morimoto, Masahiro
    Konishi, Koji
    Imamura, Fumio
    Teshima, Teruki
    Ogawa, Kazuhiko
    ANTICANCER RESEARCH, 2018, 38 (10) : 5951 - 5958
  • [10] Radiographic and clinical late effects of radiation dose escalation in patients with inoperable/unresectable non-small cell lung cancer
    Lopez, C
    Kong, FMR
    Ten Haken, R
    Cronin, P
    Tatro, D
    Quint, L
    Hayman, JA
    LUNG CANCER, 2004, 46 : S48 - S49
12345